Table 1.

Selected differential gene dependencies in AML

Gene symbolDifferential gene dependency P valueq value
MYB –1.04 3.8E-76 6.4E-84 
SDHB –0.39 1.1E-08 8.7E-07 
DHODH –0.36 1.9E-11 7.2E-10 
OGDH –0.33 3.3E-06 2.1E-04 
DLD –0.29 8.8E-08 3.1E-06 
BCL2 –0.27 1.3E-13 3.0E-12 
DLST –0.27 1.7E-08 5.5E-07 
SDHC –0.25 2.1E-05 6.9E-04 
SDHD –0.24 1.2E-06 2.9E-05 
SDHA –0.24 2.0E-07 6.3E-06 
PDXK –0.12 3.9E-07 7.3E-06 
Gene symbolDifferential gene dependency P valueq value
MYB –1.04 3.8E-76 6.4E-84 
SDHB –0.39 1.1E-08 8.7E-07 
DHODH –0.36 1.9E-11 7.2E-10 
OGDH –0.33 3.3E-06 2.1E-04 
DLD –0.29 8.8E-08 3.1E-06 
BCL2 –0.27 1.3E-13 3.0E-12 
DLST –0.27 1.7E-08 5.5E-07 
SDHC –0.25 2.1E-05 6.9E-04 
SDHD –0.24 1.2E-06 2.9E-05 
SDHA –0.24 2.0E-07 6.3E-06 
PDXK –0.12 3.9E-07 7.3E-06 

Members of the αKG dehydrogenase complex are shown in bold.

Difference in AML vs other cancers of normalized depletion of sgRNAs targeting individual genes across available CRISPR screens.

Close Modal

or Create an Account

Close Modal
Close Modal